These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 27924718)

  • 1. Co-Activation of Cultured Human Natural Killer Cells: Enhanced Function and Decreased Inhibition.
    Urlaub D; Bhat R; Messmer B; Watzl C
    J Toxicol Environ Health A; 2016; 79(22-23):1078-1084. PubMed ID: 27924718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of activating and inhibitory receptor signaling by regulated phosphorylation of Vav1 in immune cells.
    Mesecke S; Urlaub D; Busch H; Eils R; Watzl C
    Sci Signal; 2011 May; 4(175):ra36. PubMed ID: 21632469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of ligands for activating natural killer cell receptors on cell lines commonly used to assess natural killer cell function.
    Tremblay-McLean A; Coenraads S; Kiani Z; Dupuy FP; Bernard NF
    BMC Immunol; 2019 Jan; 20(1):8. PubMed ID: 30696399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A requirement for CD45 distinguishes Ly49D-mediated cytokine and chemokine production from killing in primary natural killer cells.
    Huntington ND; Xu Y; Nutt SL; Tarlinton DM
    J Exp Med; 2005 May; 201(9):1421-33. PubMed ID: 15867094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD160-activating NK cell effector functions depend on the phosphatidylinositol 3-kinase recruitment.
    Rabot M; El Costa H; Polgar B; Marie-Cardine A; Aguerre-Girr M; Barakonyi A; Valitutti S; Bensussan A; Le Bouteiller P
    Int Immunol; 2007 Apr; 19(4):401-9. PubMed ID: 17307798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer cell receptors: alterations and therapeutic targeting in malignancies.
    Konjević G; Vuletić A; Mirjačić Martinović K
    Immunol Res; 2016 Feb; 64(1):25-35. PubMed ID: 26374324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cell tolerance licensing and other mechanisms.
    Jonsson AH; Yokoyama WM
    Adv Immunol; 2009; 101():27-79. PubMed ID: 19231592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome wide transcriptional analysis of resting and IL2 activated human natural killer cells: gene expression signatures indicative of novel molecular signaling pathways.
    Dybkaer K; Iqbal J; Zhou G; Geng H; Xiao L; Schmitz A; d'Amore F; Chan WC
    BMC Genomics; 2007 Jul; 8():230. PubMed ID: 17623099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human leukocyte antigen-G1 inhibits natural killer cytotoxicity through blocking the activating signal transduction pathway and formation of activating immunologic synapse.
    Yu Y; Wang Y; Feng M
    Hum Immunol; 2008 Jan; 69(1):16-23. PubMed ID: 18295671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rapid method for assessment of natural killer cell function after multiple receptor crosslinking.
    Al-Hubeshy ZB; Coleman A; Nelson M; Goodier MR
    J Immunol Methods; 2011 Mar; 366(1-2):52-9. PubMed ID: 21281644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decitabine has a biphasic effect on natural killer cell viability, phenotype, and function under proliferative conditions.
    Kopp LM; Ray A; Denman CJ; Senyukov VS; Somanchi SS; Zhu S; Lee DA
    Mol Immunol; 2013 Jul; 54(3-4):296-301. PubMed ID: 23328088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cell signaling pathways.
    Vivier E; Nunès JA; Vély F
    Science; 2004 Nov; 306(5701):1517-9. PubMed ID: 15567854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role for the Rac1 exchange factor Vav in the signaling pathways leading to NK cell cytotoxicity.
    Galandrini R; Palmieri G; Piccoli M; Frati L; Santoni A
    J Immunol; 1999 Mar; 162(6):3148-52. PubMed ID: 10092764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research Progress on NK Cell Receptors and Their Signaling Pathways.
    Chen Y; Lu D; Churov A; Fu R
    Mediators Inflamm; 2020; 2020():6437057. PubMed ID: 32774149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Balancing natural killer cell activation through paired receptors.
    Martinet L; Smyth MJ
    Nat Rev Immunol; 2015 Apr; 15(4):243-54. PubMed ID: 25743219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of several activating and inhibitory receptors on CD3(-)CD56(+) NK cells in regional lymph nodes of melanoma patients.
    Vuletić A; Jurišić V; Jovanić I; Milovanović Z; Nikolić S; Konjević G
    J Surg Res; 2013 Aug; 183(2):860-8. PubMed ID: 23522458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells.
    Upshaw JL; Arneson LN; Schoon RA; Dick CJ; Billadeau DD; Leibson PJ
    Nat Immunol; 2006 May; 7(5):524-32. PubMed ID: 16582911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein tyrosine phosphorylation and p56lck modification in IL-2 or phorbol ester-activated human natural killer cells.
    Einspahr KJ; Abraham RT; Dick CJ; Leibson PJ
    J Immunol; 1990 Sep; 145(5):1490-7. PubMed ID: 1696599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NK cell function triggered by multiple activating receptors is negatively regulated by glycogen synthase kinase-3β.
    Kwon HJ; Kwon SJ; Lee H; Park HR; Choi GE; Kang SW; Kwon SW; Kim N; Lee SY; Ryu S; Kim SC; Kim HS
    Cell Signal; 2015 Sep; 27(9):1731-41. PubMed ID: 26022178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CD20 Therapy Acts via FcγRIIIA to Diminish Responsiveness of Human Natural Killer Cells.
    Capuano C; Romanelli M; Pighi C; Cimino G; Rago A; Molfetta R; Paolini R; Santoni A; Galandrini R
    Cancer Res; 2015 Oct; 75(19):4097-108. PubMed ID: 26229120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.